Skip to main content
Getinge logo

Getinge — Investor Relations & Filings

Ticker · GETI ISIN · SE0000202624 LEI · 5493003PZ4F570G3W735 ST Manufacturing
Open in API
Filings indexed 648 across all filing types
Latest filing 2014-06-23 Report Publication Anno…
Country SE Sweden
Listing ST GETI

About Getinge

https://www.getinge.com/int/

Getinge is a global medical technology company that provides products and solutions for hospitals and life science institutions. The company's offerings are designed to improve clinical outcomes and support healthcare professionals. Its portfolio is focused on three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Key products include equipment and systems for intensive care, cardiovascular procedures, operating rooms, and sterile reprocessing. Notable solutions feature advanced ventilators like the Servo-u, extracorporeal life support systems such as Cardiohelp II, and equipment for biopharmaceutical production. The company also offers training and educational services to enhance clinical expertise.

Recent filings

Filing Released Lang Actions
Getinge announces date of 2014 Q2 report and conference call
Report Publication Announcement Classification · 99% confidence The document is a press release dated June 23, 2014, announcing the date and time for the release of the 'Q2 report for 2014' and the subsequent conference call. It provides dial-in details, agenda, and access to the presentation for the call. Since the document is short (2197 chars) and its primary function is to announce the publication of a future report and associated call, it fits the definition of a Report Publication Announcement (RPA). It is not the Q2 report itself (which would likely be an IR or ER), nor is it the transcript of the call (CT).
2014-06-23 English
Getinge senarelägger Kapitalmarknadsdagen planerad till den 27 maj
Report Publication Announcement Classification · 99% confidence The document is a press release dated May 25, 2014, announcing the postponement of the 'Kapitalmarknadsdagen' (Capital Markets Day) scheduled for May 27th. It discusses ongoing dialogue with the FDA regarding quality management systems and mentions that the information will be followed up with a conference call including an introduction and Q&A session. Since the document is an announcement about a future event (Capital Markets Day) and provides details for an immediate conference call (which is a form of earnings/update call), it is primarily functioning as a regulatory or corporate update. Given the context of announcing a delay to a major investor event and immediately scheduling a conference call to discuss the situation, it fits best under a general regulatory announcement or an update related to investor relations/corporate events. It is not a full report (10-K, IR), a formal earnings release (ER), or a transcript (CT). Since it is a specific corporate announcement that doesn't fit the highly specific categories like DIV, DIRS, or MANG, the most appropriate general category is Regulatory Filings (RNS), as it is a formal press release detailing a change in corporate schedule related to regulatory dialogue (FDA). The document length is short (2261 chars), but it is not announcing the publication of another report, rather it is the primary communication itself.
2014-05-25 Swedish
Getinge postpones 27 May Capital Markets Day and reschedules for a later date to be announced
Regulatory Filings Classification · 95% confidence The document is a short press release dated May 25, 2014, announcing the postponement of a 'Capital Markets Day'. It discusses ongoing discussions with the FDA regarding quality management systems and mentions that a conference call will follow this announcement. Since the primary content is an announcement about rescheduling an event and providing details for an upcoming conference call (which is a form of communication with investors/analysts), it does not fit the definition of a full report (10-K, IR), a specific financial event (ER, DIV), or a management change (MANG). It is an announcement related to investor relations and corporate events. Given the options, this type of announcement, which is not a formal regulatory filing like a 10-K or a specific financial release like an ER, is best categorized as a general Regulatory Filing (RNS) or potentially related to Investor Presentation (IP) if the CMD was meant to be one. However, since it is a general press release about corporate scheduling and ongoing regulatory dialogue, RNS serves as the most appropriate general regulatory/corporate announcement fallback, although it is very close to an Investor Presentation context. Given the short length and the nature of the announcement (postponement and follow-up call details), RNS is the safest classification for a non-standard, time-sensitive corporate update.
2014-05-25 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Templeton Global Advisors, Limited) in the issuer (Getinge AB). It explicitly states the 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures, including the new percentage (5.13%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2014-05-08 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report ('Delårsrapport') for Getingekoncernen covering the period January to March 2014. It contains detailed financial statements, including income statements, order intake analysis, segment reporting (Medical Systems, Extended Care), and management commentary on business performance and outlook. It is clearly a comprehensive interim report rather than a summary or announcement. Q1 2014
2014-04-16 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the period of January to March 2014 (Q1). It contains detailed financial statements, including order intake, net sales, profit/loss, earnings per share, and EBITA, along with management's analysis of business areas (Medical Systems, Extended Care) and outlook. It is not an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report. Q1 2014
2014-04-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.